Clinical Trial Update: Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of Phase 2 testing of zileuton for idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Zileuton (zileuton)

Snippet

Sponsor: University of Michigan | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED